Karapanagiotou, Eleni M <br/><br/>
A phase II study of sequential docetaxel and gemcitabine followed by docetaxel and carboplatin as first-line therapy for non-small cell lung cancer.  [electronic resource] 

 -  Medical oncology (Northwood, London, England)  2008 
 - 303-8 p.  digital 
<br/><br/> Publication Type: Clinical Trial, Phase II; Journal Article 
<br/><br/><label>ISSN: </label>1357-0560 
<br/><br/><label>Standard No.: </label>10.1007/s12032-007-9036-9  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Aged<br/>Antineoplastic Combined Chemotherapy Protocols--adverse effects<br/>Carboplatin--administration & dosage<br/>Carcinoma, Non-Small-Cell Lung--drug therapy<br/>Deoxycytidine--administration & dosage<br/>Docetaxel<br/>Female<br/>Humans<br/>Kaplan-Meier Estimate<br/>Lung Neoplasms--drug therapy<br/>Male<br/>Middle Aged<br/>Taxoids--administration & dosage<br/>Gemcitabine